Furthermore, signaling through the ALK‐1 pathway may represent one of the mechanisms allowing tumor escape from the inhibitory effects of vascular endothelial growth factor (VEGF)‐targeted therapies 11, 12. The gene discussed is VEGFA; the disease is neoplasm.